Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage

OBJECTIVES: The benefit of adjuvant chemotherapy in patients with localized uterine leiomyosarcoma (LMS) remains unclear due to a lack of randomized studies and data only from small retrospective series to rely on. We sought to identify factors associated with the administration of chemotherapy and...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Sarcoma
Главные авторы: Patel, Dhara, Handorf, Elizabeth, von Mehren, Margaret, Martin, Lainie, Movva, Sujana
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2019
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6387708/
https://ncbi.nlm.nih.gov/pubmed/30881199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3561501
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы